Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions ; volume:10 ; number:1 ; day:6 ; month:5 ; year:2024 ; pages:1-15 ; date:12.2024
Future Journal of Pharmaceutical Sciences ; 10, Heft 1 (6.5.2024), 1-15, 12.2024
- Urheber
-
Mahmoud, Aalaa Mahmoud Ahmed Shawqi
El Said, Nouran Omar
Shash, Emad
Ateyya, Hayam
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43094-024-00638-w
- URN
-
urn:nbn:de:101:1-2407152108042.924699240731
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mahmoud, Aalaa Mahmoud Ahmed Shawqi
- El Said, Nouran Omar
- Shash, Emad
- Ateyya, Hayam
- SpringerLink (Online service)
Ähnliche Objekte (12)
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Diagnosis of peripheral neuropathy
Pharmacological and non-pharmacological interventions in management of peripheral venipuncture-related pain: a randomized clinical trial
Painful Peripheral Neuropathy and Cancer
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
Peripheral endovascular interventions
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Diagnosis of peripheral neuropathy
Pharmacological and non-pharmacological interventions in management of peripheral venipuncture-related pain: a randomized clinical trial
Painful Peripheral Neuropathy and Cancer
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
Peripheral endovascular interventions
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
Incidence of Neuropathy with Weekly Paclitaxel and Role of Oral Glutamine Supplementation for Prevention of Paclitaxel Induced Peripheral Neuropathy Randomized Controlled Trial
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Diagnosis of peripheral neuropathy
Pharmacological and non-pharmacological interventions in management of peripheral venipuncture-related pain: a randomized clinical trial
Painful Peripheral Neuropathy and Cancer
Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer
Corydalis saxicola Bunting total alkaloids attenuate paclitaxel-induced peripheral neuropathy through PKCε/p38 MAPK/TRPV1 signaling pathway
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
Peripheral endovascular interventions